(19)
(11) EP 2 490 691 A1

(12)

(43) Date of publication:
29.08.2012 Bulletin 2012/35

(21) Application number: 10766293.4

(22) Date of filing: 20.10.2010
(51) International Patent Classification (IPC): 
A61K 31/517(2006.01)
A61P 25/08(2006.01)
(86) International application number:
PCT/EP2010/065805
(87) International publication number:
WO 2011/048150 (28.04.2011 Gazette 2011/17)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.10.2009 US 253336 P
22.07.2010 EP 10170544

(71) Applicant: Novartis AG
4056 Basel (CH)

(72) Inventors:
  • ALLGEIER, Hans
    79541 Loerrach (DE)
  • AUBERSON, Yves
    CH-4002 Basel (CH)
  • AVRAMEAS, Alexandre
    CH-4002 Basel (CH)
  • BLAETTLER, Thomas
    CH-4460 Gelterkinden (CH)
  • CARCACHE, David
    CH-4002 Basel (CH)
  • FLOERSHEIM, Philipp
    CH-4002 Basel (CH)
  • FROESTL, Wolfgang
    CH-1024 Ecublens (CH)
  • GUIBOURDENCHE, Christel
    CH-4002 Basel (CH)
  • KALKMAN, Hans, O.
    CH-4002 Basel (CH)
  • KALLEN, Joerg
    CH-4002 Basel (CH)
  • KOLLER, Manuel
    CH-4002 Basel (CH)
  • LINGENHÖHL, Kurt
    CH-4002 Basel (CH)
  • MA, Shenglin
    Shanghai 201203 (CN)
  • MATTES, Henri
    CH-4002 Basel (CH)
  • NOZULAK, Joachim
    CH-4002 Basel (CH)
  • ORAIN, David
    CH-4002 Basel (CH)
  • RENAUD, Johanne
    CH-4053 Basel (CH)
  • STROHMAIER, Christine
    CH-4002 Basel (CH)

(74) Representative: Hutchison, John Robert 
Novartis Pharma AG Patent Department
4002 Basel
4002 Basel (CH)

   


(54) USE OF 1H-QUINAZOLINE-2,4-DIONES